Blood test could revolutionize breast cancer monitoring
Knowledge-focused
Recruiting now
This study is testing a device called ScreenCell that counts circulating tumor cells (CTCs) in a blood sample from breast cancer patients. Researchers want to see if changes in CTC numbers over time can help track how the cancer is progressing. The study will include 93 women wit…
Phase: NA • Sponsor: ScreenCell • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC